Cyclopharm Ltd (CYC.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -38 | -206 | -641 | -1,795 | -12 |
| Net Acquisitions | -343 | -681 | -1,003 | N/A | N/A |
| Purchase Sale Intangibles | -439 | -1,893 | -1,068 | N/A | N/A |
| Other Investing Activity | 0 | 87 | 1,176 | -426 | -639 |
| Investing Cash Flow | $-820 | $-2,694 | $-1,537 | $-2,221 | $-652 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -59 | -54 | -160 | -197 | -48 |
| Common Stock Issued | 9,775 | N/A | 6,948 | N/A | N/A |
| Common Stock Repurchased | -413 | N/A | -359 | N/A | N/A |
| Dividend Paid | -661 | -651 | -600 | -557 | -278 |
| Other Financing Activity | -551 | 353 | 0 | 0 | 0 |
| Financing Cash Flow | $8,091 | $-352 | $5,828 | $-754 | $-327 |
| Exchange Rate Effect | 24 | 28 | 89 | 466 | 0 |
| Beginning Cash Position | 5,855 | 8,690 | 4,591 | 6,445 | 3,268 |
| End Cash Position | 12,660 | 5,855 | 8,690 | 4,591 | 6,445 |
| Net Cash Flow | $6,781 | $-2,863 | $4,010 | $-2,320 | $3,177 |
| Free Cash Flow | |||||
| Capital Expenditure | -477 | -2,100 | -1,709 | -1,795 | -652 |
| Free Cash Flow | -477 | -2,100 | -1,709 | -1,795 | -652 |